Maca Clinical Trials Recruiting Now

Maca trials recruiting now

1 registration that name maca as a study arm and are recruiting or about to, as ClinicalTrials.gov listed them on Oct 20, 2026. Read each listing for its full criteria and current status.

Trial Finder Read from ClinicalTrials.gov Oct 20, 2026 The Maca supplement page

Kymata never assesses eligibility. Each listing names its own criteria; only its study team can say whether someone can join. Trial doses are given under the trial's monitoring and are not a schedule for anyone outside it.

Not yet recruitingNCT07816172

Effects of Macanity on Urinary Health in Males With Lower Urinary Tract Symptoms

Phase 2
RDC Clinical Pty Ltd
About 200 people
Starts Sep 2026 (estimated)

In plain words A Phase 2 study of maca in male participants 40 and older, run by RDC Clinical Pty Ltd. It plans to enroll about 200 people at 1 site, none in the US.

Who it lists and where

Who the trial lists, as registered

Lists male participants 40 and older; healthy volunteers accepted. Conditions: Lower Urinary Tract Symptoms (LUTS).

Adult males > 40 years of age experiencing LUTS
Generally healthy
BMI 18-32 kg/m2
Moderate International Prostate Symptom Score (IPSS) score: 8-19.

3 more inclusion criteria and the exclusion criteria are on the listing.

What it tests, as registered

Maca Root; Placebo

Registered summary

The goal of this study is to evaluate the effects of Macanity on urinary health in males experiencing LUTS. Males aged over 40 years of age who experience LUTS will be recruited and assigned to a study treatment which they will take for 12 weeks. They will have 3 remote visits over 12 weeks.

Where, as registered

No US site; Australia (1).